These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21423295)

  • 21. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
    Choi WS; Lee JJ; Kim Y; Kim IS; Zhang WY; Myung CS
    Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.
    Qi Z; Xue J; Zhang Y; Wang H; Xie M
    Planta Med; 2011 Feb; 77(3):231-5. PubMed ID: 20717873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers.
    Abdin AA; Baalash AA; Hamooda HE
    J Diabetes Complications; 2010; 24(3):168-78. PubMed ID: 19328014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
    Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
    Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia.
    Inoue M; Yano M; Yamakado M; Maehata E; Suzuki S
    Metabolism; 2006 Sep; 55(9):1248-54. PubMed ID: 16919546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk reduction therapy for syndrome X: comparison of several treatments.
    Oron-Herman M; Sela BA; Rosenthal T
    Am J Hypertens; 2005 Mar; 18(3):372-8. PubMed ID: 15797656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiomyopathy in insulin resistance type 2 diabetes mellitus rats.
    Sharma AK; Srinivasan BP
    Eur J Pharm Sci; 2009 Dec; 38(5):433-44. PubMed ID: 19765654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes.
    Skovsø S; Damgaard J; Fels JJ; Olsen GS; Wolf XA; Rolin B; Holst JJ
    Int J Obes (Lond); 2015 Oct; 39(10):1531-8. PubMed ID: 26121961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndrome.
    Samaha FF; Szapary PO; Iqbal N; Williams MM; Bloedon LT; Kochar A; Wolfe ML; Rader DJ
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):624-30. PubMed ID: 16357312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome.
    Aquilante CL; Kosmiski LA; Zineh I; Rome LC; Knutsen SD
    Pharmacotherapy; 2010 Mar; 30(3):236-47. PubMed ID: 20180607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
    Ran J; Hirano T; Fukui T; Saito K; Kageyama H; Okada K; Adachi M
    Metabolism; 2006 Apr; 55(4):478-88. PubMed ID: 16546478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome.
    Esposito K; Ciotola M; Carleo D; Schisano B; Saccomanno F; Sasso FC; Cozzolino D; Assaloni R; Merante D; Ceriello A; Giugliano D
    Diabetes Care; 2006 May; 29(5):1071-6. PubMed ID: 16644639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adiponectin is independently associated with apolipoprotein B to A-1 ratio in Koreans.
    Park JS; Cho MH; Nam JS; Yoo JS; Lee YB; Roh JM; Ahn CW; Jee SH; Cha BS; Lee EJ; Lim SK; Kim KR; Lee HC
    Metabolism; 2010 May; 59(5):677-82. PubMed ID: 19914667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Change of glucose transporter 4 and its influence on glucose and fatty-acid metabolism in type 2 diabetic myocardium].
    Wen ZY; Wu Y; Li Y; Chen XL; Wang T; Ouyang JP; Li GS
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1460-3. PubMed ID: 16061022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome.
    Güçlü F; Ozmen B; Hekimsoy Z; Kirmaz C
    Biomed Pharmacother; 2004 Dec; 58(10):614-8. PubMed ID: 15589072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of renin inhibition on adipokines in diabetic rats.
    Hassanin A; Malek HA
    Pak J Pharm Sci; 2014 Jul; 27(4):767-72. PubMed ID: 25015438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
    Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N
    Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Protective effects of Huanglian Jiedu decoction on vascular endothelial function in type 2 diabetic rats].
    Xiao YL; Lu FE; Xu LJ; Leng SH; Wang KF
    Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(22):1767-70. PubMed ID: 16468376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.